secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prelude Therapeutics Inc (PRLD)
CIK:        0001678660
Form:       8-K
Filed at:   2023-06-01T23:59:59+00:00
Accession:  0000950170-23-025712
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prelude Therapeutics furnishes May 2023 investor presentation
-------------------------------------------------------------

- Company prepared investor presentation materials for use in investor meetings.
- Presentation provided as Exhibit 99.1, furnished under Regulation FD, not filed.
- No specific financial or pipeline updates disclosed in the 8-K filing body.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1678660/000095017023025712/0000950170-23-025712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1678660/000095017023025712/prld-20230601.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-025712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer